ropivacaine

1
Reactions 984 - 17 Jan 2004 S Ropivacaine Ventricular fibrillation in an elderly patient: case report Ventricular fibrillation occurred in a 76-year-old woman following the administration of ropivacaine for anterior sciatic block prior to foot osteotomy. She was also taking olanzapine and citalopram. The woman was sedated and underwent a femoral block with mepivacaine. An anterior sciatic block was then achieved with 0.5% ropivacaine. After receiving 32mL (160mg) of ropivacaine she became less responsive and the agent was discontinued. Within 5–10 seconds she developed tachycardia and experienced twitching of her face and hand. The twitching rapidly progressed to a tonic-clonic seizure despite treatment with midazolam. The woman was ventilated and her seizures were stopped with propofol. She remained unresponsive and was intubated. Her pulse rate slowed and within 3 minutes of the ropivacaine injection ventricular fibrillation occurred. Chest compressions were performed for 60 seconds. She then converted to sinus bradycardia and within a further minute she began to make respiratory efforts. She was alert and breathing regularly 10 minutes after the injection. A venous blood sample taken 5 minutes after receiving ropivacaine revealed a total plasma ropivacaine concentration of 3.2 mg/L and a free plasma ropivacaine concentration of 0.5 mg/L. The woman’s surgery was completed and she was discharged from hospital the following day without further complications. Author comment: "The serum ropivacaine concentrations suggest that a portion of the 160mg dose entered the circulation contributing to the cardiac arrest." The woman was also taking olanzapine and citalopram and these agents "may have increased the sensitivity to the arrhythmogenic effects of ropivacaine". Klein SM, et al. Successful resuscitation after ropivacaine-induced ventricular fibrillation. Anesthesia and Analgesia 97: 901-903, No. 3, Sep 2003 - USA 800953592 1 Reactions 17 Jan 2004 No. 984 0114-9954/10/0984-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: dotuong

Post on 18-Mar-2017

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ropivacaine

Reactions 984 - 17 Jan 2004

SRopivacaine

Ventricular fibrillation in an elderly patient: casereport

Ventricular fibrillation occurred in a 76-year-old womanfollowing the administration of ropivacaine for anterior sciaticblock prior to foot osteotomy. She was also taking olanzapineand citalopram.

The woman was sedated and underwent a femoral blockwith mepivacaine. An anterior sciatic block was then achievedwith 0.5% ropivacaine. After receiving 32mL (160mg) ofropivacaine she became less responsive and the agent wasdiscontinued. Within 5–10 seconds she developed tachycardiaand experienced twitching of her face and hand. The twitchingrapidly progressed to a tonic-clonic seizure despite treatmentwith midazolam.

The woman was ventilated and her seizures were stoppedwith propofol. She remained unresponsive and was intubated.Her pulse rate slowed and within 3 minutes of the ropivacaineinjection ventricular fibrillation occurred. Chest compressionswere performed for 60 seconds. She then converted to sinusbradycardia and within a further minute she began to makerespiratory efforts. She was alert and breathing regularly10 minutes after the injection.

A venous blood sample taken 5 minutes after receivingropivacaine revealed a total plasma ropivacaine concentrationof 3.2 mg/L and a free plasma ropivacaine concentration of0.5 mg/L.

The woman’s surgery was completed and she wasdischarged from hospital the following day without furthercomplications.

Author comment: "The serum ropivacaine concentrationssuggest that a portion of the 160mg dose entered thecirculation contributing to the cardiac arrest." The womanwas also taking olanzapine and citalopram and these agents"may have increased the sensitivity to the arrhythmogeniceffects of ropivacaine".Klein SM, et al. Successful resuscitation after ropivacaine-induced ventricularfibrillation. Anesthesia and Analgesia 97: 901-903, No. 3, Sep 2003 -USA 800953592

1

Reactions 17 Jan 2004 No. 9840114-9954/10/0984-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved